| Item | Current | Prior | YoY % |
|---|---|---|---|
| Net Sales | ¥58.75B | ¥56.62B | +3.8% |
| Cost of Sales | ¥25.21B | ¥23.70B | +6.4% |
| Gross Profit | ¥33.54B | ¥32.92B | +1.9% |
| SG&A Expenses | ¥23.00B | ¥21.53B | +6.8% |
| Operating Income | ¥10.54B | ¥11.39B | -7.5% |
| Non-operating Income | ¥1.01B | ¥1.31B | -23.0% |
| Non-operating Expenses | ¥616M | ¥423M | +45.6% |
| Ordinary Income | ¥10.93B | ¥12.28B | -11.0% |
| Profit Before Tax | ¥11.05B | ¥12.00B | -7.9% |
| Income Tax Expense | ¥4.87B | ¥3.92B | +24.2% |
| Net Income | ¥6.18B | ¥8.08B | -23.5% |
| Net Income Attributable to Owners | ¥6.18B | ¥8.08B | -23.5% |
| Total Comprehensive Income | ¥5.14B | ¥9.09B | -43.5% |
| Interest Expense | ¥126M | ¥42M | +200.1% |
| Basic EPS | ¥73.85 | ¥95.42 | -22.6% |
| Diluted EPS | ¥73.61 | ¥95.13 | -22.6% |
| Dividend Per Share | ¥26.00 | ¥26.00 | +0.0% |
| Item | Current End | Prior End | Change |
|---|---|---|---|
| Current Assets | ¥92.40B | ¥84.89B | +¥7.51B |
| Cash and Deposits | ¥53.46B | ¥46.05B | +¥7.41B |
| Accounts Receivable | ¥9.12B | ¥9.36B | ¥-234M |
| Inventories | ¥13.27B | ¥12.98B | +¥294M |
| Non-current Assets | ¥70.07B | ¥73.41B | ¥-3.34B |
| Item | Value |
|---|---|
| Net Profit Margin | 10.5% |
| Gross Profit Margin | 57.1% |
| Current Ratio | 381.4% |
| Quick Ratio | 326.6% |
| Debt-to-Equity Ratio | 0.36x |
| Interest Coverage Ratio | 83.92x |
| Effective Tax Rate | 44.1% |
| Item | YoY Change |
|---|---|
| Net Sales YoY Change | +3.8% |
| Operating Income YoY Change | -7.5% |
| Ordinary Income YoY Change | -11.0% |
| Net Income Attributable to Owners YoY Change | -23.5% |
| Total Comprehensive Income YoY Change | -43.5% |
| Item | Value |
|---|---|
| Shares Outstanding (incl. Treasury) | 93.42M shares |
| Treasury Stock | 10.23M shares |
| Average Shares Outstanding | 83.70M shares |
| Book Value Per Share | ¥1,437.35 |
| Item | Amount |
|---|---|
| Q2 Dividend | ¥26.00 |
| Year-End Dividend | ¥26.00 |
| Segment | Revenue | Operating Income |
|---|---|---|
| DCIProducts | ¥14.69B | ¥-332M |
| DentalProducts | ¥35.04B | ¥12.18B |
| IndustrialProducts | ¥5.11B | ¥596M |
| SurgicalProducts | ¥4.17B | ¥2.28B |
| Item | Forecast |
|---|---|
| Net Sales Forecast | ¥80.66B |
| Operating Income Forecast | ¥13.15B |
| Ordinary Income Forecast | ¥13.84B |
| Net Income Attributable to Owners Forecast | ¥8.37B |
| Basic EPS Forecast | ¥99.14 |
| Dividend Per Share Forecast | ¥28.00 |
| Property, Plant & Equipment | ¥26.29B | ¥25.13B | +¥1.16B |
| Intangible Assets | ¥34.51B | ¥38.20B | ¥-3.68B |
| Goodwill | ¥19.09B | ¥21.39B | ¥-2.30B |
| Investment Securities | ¥4.82B | ¥5.85B | ¥-1.03B |
| Total Assets | ¥162.47B | ¥158.30B | +¥4.17B |
| Current Liabilities | ¥24.23B | ¥27.93B | ¥-3.70B |
| Accounts Payable | ¥3.42B | ¥2.65B | +¥770M |
| Short-term Loans | ¥5.67B | ¥13.92B | ¥-8.25B |
| Non-current Liabilities | ¥18.67B | ¥9.17B | +¥9.50B |
| Long-term Loans | ¥13.01B | ¥2.98B | +¥10.04B |
| Total Liabilities | ¥42.90B | ¥37.10B | +¥5.80B |
| Total Equity | ¥119.56B | ¥121.20B | ¥-1.64B |
| Capital Stock | ¥868M | ¥868M | ¥0 |
| Capital Surplus | ¥2.59B | ¥2.58B | +¥3M |
| Retained Earnings | ¥118.63B | ¥116.59B | +¥2.03B |
| Treasury Stock | ¥-14.67B | ¥-12.03B | ¥-2.65B |
| Owners' Equity | ¥119.17B | ¥120.82B | ¥-1.65B |
| Working Capital | ¥68.17B | - | - |